Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
OPERATING ACTIVITIES:
Net loss	$ (27,331)	$ (23,233)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	136	188
Provision for sales returns	236	128
Amortization of deferred financing costs and debt discounts	914	337
Stock-based compensation	11,835	482
Other	101	62
Changes in assets and liabilities:
Accounts receivable	(1,784)	48
Inventory	4,944	(515)
Prepaid and other current assets	(2,307)	(2,757)
Accounts payable, accrued and other liabilities	110	5,731
Cash used in operating activities	(13,146)	(19,529)
INVESTING ACTIVITIES:
Purchase of fixed assets	(48)	(25)
Purchase of Aussie Health Co. assets	(1,105)
Proceeds on sale of fixed assets	6	35
Cash provided by (used in) investing activities	(1,147)	10
FINANCING ACTIVITIES:
Proceeds from exercise of stock options	2	18
Proceeds from Initial Public Offering	36,000
Issuance costs of stock		(17)
Borrowings from Mid Cap credit facility	69,740	37,048
Repayments from Mid Cap credit facility	(71,082)	(32,519)
Repayments from Mid Cap term loan		(1,344)
Insurance financing proceeds	3,833
Insurance obligation payments	(1,818)
Capital lease financing proceeds		20
Capital lease obligation payments	(42)	(40)
Cash provided by financing activities	29,706	30,186
EFFECT OF EXCHANGE RATE ON CASH	1
NET CHANGE IN CASH AND RESTRICTED CASH FOR PERIOD	15,414	10,667
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD	20,708	5,797	$ 5,797
CASH AND RESTRICTED CASH AT END OF PERIOD	36,122	16,464	20,708
RECONCILIATION OF CASH AND RESTRICTED CASH
CASH	35,686	15,785
RESTRICTED CASH—Prepaid and other assets	307	550
RESTRICTED CASH—Other non-current assets	129	129
CASH AND RESTRICTED CASH AT END OF PERIOD	36,122	16,464	20,708
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest	2,467	1,112
Cash paid for taxes	15	3
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital lease		25
Note payable on acquisition	195
Initial Public Offering
FINANCING ACTIVITIES:
Issuance costs of stock	(5,446)
Series C Preferred Stock
FINANCING ACTIVITIES:
Proceeds from issuance of preferred stock - converted to common stock		23,061
Issuance costs of stock		(3,000)
Series C-1 Preferred Stock
FINANCING ACTIVITIES:
Proceeds from issuance of preferred stock - converted to common stock		8,364
Issuance costs of stock		(1,036)
Horizon Term Loan
FINANCING ACTIVITIES:
Repayments from Mid Cap term loan			$ (4,900)
Debt issuance costs	(900)
Mid Cap Credit Facility
FINANCING ACTIVITIES:
Debt issuance costs	$ (581)	$ (369)